Literature DB >> 25058627

Does surgery improve live birth rates in patients with recurrent miscarriage caused by uterine anomalies?

M Sugiura-Ogasawara1, B L Lin, K Aoki, T Maruyama, M Nakatsuka, N Ozawa, T Sugi, T Takeshita, M Nishida.   

Abstract

We found that congenital uterine anomalies have a negative impact on reproductive outcome in recurrent-miscarriage couples, being associated with further miscarriage with a normal embryonic karyotype. There has been no study comparing live birth rates between patients with and without surgery. We conducted a prospective study to prove that surgery for a bicornuate or septate uterus might improve the live birth rate. A total of 170 patients with congenital uterine anomalies suffering two or more miscarriages were examined. The live birth rate after ascertainment of anomalies, cumulative live birth rate and infertility rate, were compared between patients with and without surgery. In patients with a septate uterus, the live birth rate (81.3%) at the first pregnancy after ascertainment of anomalies with surgery tended to be higher than that (61.5%) in those without surgery. The infertility rates were similar in both groups, while the cumulative live birth rate (76.1%) tended to be higher than without surgery (60.0%). Surgery showed no benefit in patients with a bicornuate uterus for having a baby, but tended to decrease the preterm birth rate and the low birth weight. The possibility that surgery has benefits for having a baby in patients with a septate uterus suffering recurrent miscarriage could not be excluded.

Entities:  

Keywords:  Bicornuate uterus; congenital uterine anomaly; metroplasty; recurrent pregnancy loss; septate uterus

Mesh:

Year:  2014        PMID: 25058627     DOI: 10.3109/01443615.2014.936839

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  6 in total

Review 1.  Uterine Septum with or without Hysteroscopic Metroplasty: Impact on Fertility and Obstetrical Outcomes-A Systematic Review and Meta-Analysis of Observational Research.

Authors:  Marco Noventa; Giulia Spagnol; Matteo Marchetti; Carlo Saccardi; Giulio Bonaldo; Antonio Simone Laganà; Francesco Cavallin; Alessandra Andrisani; Guido Ambrosini; Salvatore Giovanni Vitale; Luis Alonso Pacheco; Sergio Haimovich; Attilio Di Spiezio Sardo; Jose Carugno; Marco Scioscia; Simone Garzon; Stefano Bettocchi; Giovanni Buzzaccarini; Roberto Tozzi; Amerigo Vitagliano
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

2.  Septum resection in women with a septate uterus: a cohort study.

Authors:  J F W Rikken; K W J Verhorstert; M H Emanuel; M Y Bongers; T Spinder; W K H Kuchenbecker; F W Jansen; J W van der Steeg; C A H Janssen; K Kapiteijn; W A Schols; B Torrenga; H L Torrance; H R Verhoeve; J A F Huirne; A Hoek; T E Nieboer; I A J van Rooij; T J Clark; L Robinson; M D Stephenson; B W J Mol; F van der Veen; M van Wely; M Goddijn
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

3.  ESHRE guideline: recurrent pregnancy loss.

Authors:  Ruth Bender Atik; Ole Bjarne Christiansen; Janine Elson; Astrid Marie Kolte; Sheena Lewis; Saskia Middeldorp; Willianne Nelen; Braulio Peramo; Siobhan Quenby; Nathalie Vermeulen; Mariëtte Goddijn
Journal:  Hum Reprod Open       Date:  2018-04-06

Review 4.  Pregnancy and Adverse Obstetric Outcomes After Hysteroscopic Resection: A Systematic Review and Meta-Analysis.

Authors:  Xue Wu; Mei Zhang; Ping Sun; Jing-Jing Jiang; Lei Yan
Journal:  Front Surg       Date:  2022-06-27

5.  Successful Pregnancy Outcome after Open Strassman Metroplasty for Bicornuate Uterus.

Authors:  Edgar Gulavi; Steve Kyende Mutiso; Charles Mariara Muriuki; Abraham Mukaindo Mwaniki
Journal:  Case Rep Obstet Gynecol       Date:  2018-05-31

6.  The randomised uterine septum transsection trial (TRUST): design and protocol.

Authors:  J F W Rikken; C R Kowalik; M H Emanuel; M Y Bongers; T Spinder; J H de Kruif; K W M Bloemenkamp; F W Jansen; S Veersema; A G M G J Mulders; A L Thurkow; K Hald; A Mohazzab; Y Khalaf; T J Clark; M Farrugia; H A van Vliet; M S Stephenson; F van der Veen; M van Wely; B W J Mol; M Goddijn
Journal:  BMC Womens Health       Date:  2018-10-05       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.